Jupiter Neurosciences grants 525,565 options to CFO
JUPITER NEUROSCIENCES, INC. reported a compensation-related stock option grant to its Chief Financial Officer, Saleem Elmasri.
Rhea-AI Filing Summary
JUPITER NEUROSCIENCES, INC. reported a compensation-related stock option grant to its Chief Financial Officer, Saleem Elmasri. He received options for 525,565 shares of common stock at an exercise price of $0.2783 per share, expiring on June 2, 2036.
According to the disclosure, 325,565 options were granted as a discretionary bonus for services during fiscal 2025 and 200,000 options were granted as long-term incentive compensation under the 2025 Equity Incentive Plan. The options vest over three years starting from September 2, 2026 in equal quarterly installments, conditioned on continued employment through each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 525,565 shares
Grant/Award
1 txn
Insider
Elmasri Saleem
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 525,565 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 525,565 contracts (Direct)
Footnotes (1)
- F1. 325,565 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. 200,000 options were granted under the Issuer's 2025 Equity Incentive Plan as long-term incentive compensation. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date.
Key Figures
Options granted: 525,565 options
Exercise price: $0.2783 per share
Expiration date: June 2, 2036
+3 more
6 metrics
Options granted
525,565 options
Total stock options granted to CFO on June 2, 2026
Exercise price
$0.2783 per share
Conversion or exercise price of granted options
Expiration date
June 2, 2036
Option expiration date
Discretionary bonus options
325,565 options
Granted for services rendered during fiscal 2025
Long-term incentive options
200,000 options
Granted as long-term incentive compensation
Post-grant derivative holdings
525,565 options
Total derivative securities following transaction
Key Terms
2025 Equity Incentive Plan, discretionary bonus, long-term incentive compensation, vesting, +1 more
5 terms
2025 Equity Incentive Plan financial
"options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus"
discretionary bonus financial
"325,565 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services"
long-term incentive compensation financial
"200,000 options were granted under the Issuer's 2025 Equity Incentive Plan as long-term incentive compensation"
Long-term incentive compensation is pay awarded to executives or key employees that vests over multiple years and is tied to future company performance, often delivered as stock, options, or multi-year cash bonuses. Think of it as a multi-year reward plan that only pays out if certain goals are met, so it aligns managers’ interests with shareholders. Investors watch it because it affects future costs, share dilution and signals how leadership is motivated to grow value over time.
vesting financial
"The options vest over three years commencing from September 2, 2026 in equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Stock Option financial
"security_title: Stock Option"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did JUNS CFO Saleem Elmasri report in this Form 4 filing?
He reported receiving a stock option grant for 525,565 shares of common stock. The options were issued as compensation under Jupiter Neurosciences’ 2025 Equity Incentive Plan, combining a discretionary bonus and long-term incentive award.
How many stock options did JUNS grant to its CFO and at what exercise price?
Jupiter Neurosciences granted 525,565 stock options to its CFO with an exercise price of $0.2783 per share. These options give him the right to buy company shares at that fixed price before expiration.
How are the 525,565 JUNS stock options for the CFO structured between bonus and long-term incentives?
Of the 525,565 options, 325,565 were granted as a discretionary bonus for fiscal 2025 services and 200,000 as long-term incentive compensation. Both components were issued under the company’s 2025 Equity Incentive Plan.
When do the JUNS CFO’s new stock options start vesting and over what period?
The options begin vesting on September 2, 2026 and vest over three years. Vesting occurs in equal quarterly installments, and each installment requires the CFO to remain employed through the applicable vesting date.
When do the newly granted JUNS stock options to the CFO expire?
The stock options granted to the CFO expire on June 2, 2036. He can only exercise them at the $0.2783 per share exercise price before this expiration date, subject to the vesting and employment conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
